Pulse nav.journalClub 트렌드 탐색 질문 연구자

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026개인정보 처리방침

⌘+K

메디케이드의 비만 치료제에 대한 주 정부 보장 및 급여 | Synapse

March 14, 2024Open Access

메디케이드에서 비만 치료제의 주 정부 보장 및 보상

Read Full Paperexternally

Key Points

Key points are not available for this paper at this time.

Abstract

이 연구는 2011년부터 2022년까지 비만 치료제에 대한 주 메디케이드 보장 정책과 메디케이드 보상의 추세를 조사합니다.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Cite this study

Liu et al. (목요일)이 이 질문을 연구했습니다.

synapsesocial.com/papers/68e73fdcb6db6435876b95cb — DOI: https://doi.org/10.1001/jama.2024.3073

Authors

B

Benjamin Y. Liu

Cornell University

B

Benjamin N. Rome

Boston University

Journals

JAMA

Actions

Institutions

Brigham and Women's Hospital

Beth Israel Deaconess Medical Center

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Spending, utilization, and price trends for anti-obesity medications in U.S. Medicaid programs: an empirical analysis from 1999 to 2023· 2025 · 2 citations
Navigating coverage: A qualitative study exploring the perceived impact of an insurance company policy to discontinue coverage of antiobesity medication· 2024 · 6 citations
Coverage for Opioid Use Disorder Medications in Medicaid Managed Care· 2025 · 2 citations
The Benefits and Costs of Treating Obesity Among Adults in the Medicaid Program· 2026
Survey-Reported Coverage in 2019-2022 and Implications for Unwinding Medicaid Continuous Eligibility· 2024 · 28 citations